---

Medical Advocates Ethics and Infectious Diseases
		Ethical Challenges Screening/Testing Refusal of Care/Services Detention Patient Exploitation Compulsory Treatment Decision-Making Reproduction Transplants End-of-Life Care Enteral Nutrition Professional Associations National Challenges         Sterilization Bioterrorism                     Prison Challenges HIV Exceptionalism           Conflicts of Interest Pharmaceutical Industry   Pregnancy HIV Prevention    Stigma Physician Reimbursement  Ethics and Disease Challenges and Duties HIV Cure Ebola Virus Disease Executions

---

Ethics Main Page

Main New and Noteworthy

Home Page

---

Medical Advocates Zidovudine (Retrovir)   Conference Citations XX International AIDS Conference 7th IAS Conference XIX International AIDS Conference   ZDV Main Page Main New/Newsworthy  Home Page       Last Update:  July 30, 2015  Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader Perinatal Journal Data are integrated with Perinatal Conference Data in the Perinatal Data Page. Pediatric Journal Data are integrated with Pediatric Conference Data in the Pediatric Data Page XX International AIDS Conference   The MiniZID study: a randomized controlled trial on safety of reduced dose (400 mg) of zidovudine compared with standard dose (600 mg) in HIV-infected patients starting antiretroviral therapy M. Rougemont, P. Nchotu Ngang, J.-C. Fampou, et al Abstract Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the antiretroviral pregnancy registry V. Vannappagari, J. Albano, N. Koram, et al Abstract 7th IAS Conference on HIV and Pathogenesis   POSTER Analysis of N348I mutation in the connection domain of HIV-1 reverse transcriptase and impact in the efficacy of zidovudine and non-nucleoside reverse transcriptase inhibitors J.C. Mendez, J.D. Yao